Clinical pharmacy services to improve management outcomes of Chronic Kidney Disease of uncertain etiology
Not Applicable
- Conditions
- Chronic Kidney Disease of uncertain etiology
- Registration Number
- SLCTR/2015/030
- Lead Sponsor
- ational Research Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow up complete
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
1. Consenting adults age over 18 years
2. Established diagnosis of Stage 3 or 4 Chronic Kidney Disease of Uncertain etiology
Exclusion Criteria
1. Patients undergoing haemodialysis at recruitment
2. Patients with a history of renal transplantation
3. Patients who do not give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drug adherence as measured by the brief medication questionnaire: A tool for screening patient adherence and barriers to adherence (Svarstad et al., 1999) [1.At the date of recruitment (baseline) and 12 months after the date of recruitment (post research)<br>]<br>
- Secondary Outcome Measures
Name Time Method 1. Blood Pressure <br>2. Blood investigations: hemoglobin, serum calcium, serum phosphate, serum creatinine, serum electrolytes <br>3. Quality of life as measured by Kidney Disease Quality of Life Short Form (KDQOL-SF<sup>TM</sup>), Version 1.3. (Hays et al, 1995).<br> [1. At the date of recruitment (baseline) and 12 months after the date of recruitment (post research) <br>2. At the date of recruitment (baseline) and 12 months after the date of recruitment (post research) <br>3.At the date of recruitment (baseline) and 12 months after the date of recruitment (post research)<br><br><br>]<br>